NGL FINE CHM share price has zoomed 4% and is presently trading at Rs 2,104.0.
Meanwhile, the BSE HEALTHCARE index is at 44,202.3 (down 0.1%).
Among the top gainers in the BSE HEALTHCARE index today are CAPLIN POINT (up 6.4%) and Pfizer (up 1.2%).
ASTRAZENECA PHARMA (down 2.3%) and ALEMBIC PHARMA (down 0.9%) are among the top losers today.
Over the last one year, NGL FINE CHM has moved up from Rs 2,013.4 to Rs 2,104.0, registering a gain of Rs 90.7 (up 4.5%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,071.8 to 44,202.3, registering a gain of 57.5% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 171.2%), SUVEN PHARMACEUTICALS (up 117.9%) and Glenmark Pharma (up 114.6%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 84,555.0 (up 0.3%).
The top gainers among the BSE Sensex today are Tech Mahindra (up 3.3%) and M&M (up 1.1%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.
In the meantime, NSE Nifty is at 25,810.9 (down 1.4%). Hero Motocorp and Reliance Ind. are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,118.7 to 84,555.0, registering a gain of 18,436.3 points (up 27.9%).
NGL FINE CHM net profit grew 8.4% YoY to Rs 92 million for the quarter ended June 2024, compared to a profit of Rs 85 million a year ago. Net sales rose 27.7% to Rs 908 million during the period as against Rs 710 million in April-June 2023.
For the year ended March 2024, NGL FINE CHM reported 101.6% increase in net profit to Rs 413 million compared to net profit of Rs 205 million during FY23. Revenue of the company grew 21.8% to Rs 3,387 million during FY24.
The current Price to earnings ratio of NGL FINE CHM, based on rolling 12 month earnings, stands at 30.9.
Equitymaster requests your view! Post a comment on "NGL FINE CHM Gains 4%; BSE HEALTHCARE Index Down 0.1%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!